Shortage Watch Free FDA drug-shortage watch

← all medications

Tiagabine Hydrochloride Tablet

Brand names: Tiagabine Hydrochloride

Category: Neurology

Not specified 4

FDA status: To Be Discontinued · Last FDA update: Apr 15, 2026 · First posted: Apr 15, 2026 · 1 manufacturers, 4 listed presentations

As of Apr 15, 2026, the FDA lists Tiagabine Hydrochloride Tablet as being discontinued. Of 4 manufacturer presentations, 4 Not specified.

Ask your pharmacist: which of the 1 manufacturers below can they order right now, and whether a different strength or form of Tiagabine Hydrochloride Tablet is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.
Presentation & package NDCManufacturerAvailabilityFDA note
Tiagabine Hydrochloride, Tablet, 2mg 30 count (NDC 0093-5030-56)
NDC 0093-5030-56
Teva Pharmaceuticals USA, Inc. Not specified Discontinuation of the manufacture of the drug
Tiagabine Hydrochloride, Tablet, 4mg 30 count (NDC 0093-5031-56)
NDC 0093-5031-56
Teva Pharmaceuticals USA, Inc. Not specified Discontinuation of the manufacture of the drug
Tiagabine Hydrochloride, Tablet, 12mg 30 count (NDC 0093-8072-56)
NDC 0093-8072-56
Teva Pharmaceuticals USA, Inc. Not specified Discontinuation of the manufacture of the drug
Tiagabine Hydrochloride, Tablet, 16mg 30 count (NDC 0093-8076-56)
NDC 0093-8076-56
Teva Pharmaceuticals USA, Inc. Not specified Discontinuation of the manufacture of the drug

Related medications in shortage

Other Neurology medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Tiagabine Hydrochloride Tablet (FDA data as of Apr 15, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Tiagabine Hydrochloride Tablet. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Tiagabine Hydrochloride Tablet.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/tiagabine-hydrochloride-tablet.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).